PMI logo

PICARD MEDICAL INC

PMINYSE AMERICAN
🏆 #5023 by market capUS Equity
$4.48▼ $0.20 (−4.48%)
After hours · at close
🔔
Track PMI
Get earnings, price moves & breaking news on Telegram
Track
24h▼ 4.5%
7d▲ 5.7%
14d▼ 29.8%
30d▼ 47.7%
ytd▼ 94.9%
1y▼ 98.9%
🏦Market Cap
$9M
Small Cap
📈Revenue Growth (YoY)
+12.5%
Healthy
📊Gross Margin
25.0%
Moderate
💵FCF Margin
-255.1%
Thin
⚖️P/S Ratio
1.5x
Cheap
Otter Score
76
Good

Trading Snapshot

Day Range
$4.44 – $4.57
52-Week Range
$2.65 – $684.00
Volume
$2.90B
Avg Volume
$2.80B
Shares Outstanding
2.1M
Next Earnings
Nov 21, 2026

Fundamentals Snapshot

Annual Revenue
$5M
Last Q Revenue
$3M
P/E Ratio
-0.2
P/S Ratio
1.5x
EPS (TTM)
$-15.08
Dividend Yield
0.00%
Dilution (1yr)
+2.3%

Why Investors Own PMI

  • ✓High-growth profile — revenue up +10.1% YoY with expanding US Equity exposure.
  • ✓Healthy economics — 47% gross margin and 27% free-cash-flow margin.
  • ✓New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

PMI logo

PICARD MEDICAL INC

PMI
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$5M▲ +12.5% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
4.0%▼ −258.7% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
−$13M▼ −6.7% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
−$16M▲ +32.0% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
1.5M▲ +2.3% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
$476K▲ +$21M YoY
StockOtter · stockotter.space

About PICARD MEDICAL INC

Picard Medical, Inc., through its associated companies, is dedicated to the entire process of medical device commercialization, from initial design and manufacturing to production, distribution, marketing, and sales. A key product in its portfolio is the SynCardia TAH, a sophisticated total artificial heart specifically engineered to supplant a failing human heart in individuals afflicted with advanced cardiac disease. The firm's market presence extends across the United States, Europe, and other international regions. Established in 2021, Picard Medical maintains its primary operations in Tucson, Arizona, functioning as a direct subsidiary of Hunniwell Picard I, Llc.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)
💎Quality★★★★★
🚀Growth★★★★★
⚖️Valuation★★★★★
⚡Momentum★★★★★
💧Dilution★★★★★
Overall Score
Good
76/100

Analyst Price Target

ⓘ
Average Target
$4.74
▲ +5.8% Upside
High Target$5.36
Low Target$4.17
Based on 28 analysts

Latest News & Updates

🚀
Reuters·2h ago

PICARD MEDICAL INC tops quarterly estimates as demand accelerates

Revenue grew double digits with management guiding above consensus; margins continued to expand.

🛰️
MarketWatch·5h ago

Analysts lift PMI price targets on improving margins

Several firms raised targets, citing stronger free cash flow and a healthier backlog.

🌌
MarketWatch·1d ago

PICARD MEDICAL INC announces new agreement to expand its footprint

The move broadens the company’s reach and could add incremental revenue over the next year.